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Digital holographic microscopy
for diabetes screening
Ana Doblas, Manuel Martı´nez-Corral, and Genaro Saavedra
A digital holographic microscope operating in telecentric mode could
be used to diagnose diabetes and evaluate long-term glycemic control
in patients with diabetes.
Transparent objects, such as live biological cells, are difficult
to observe and quantify using traditional light microscopes
owing to lack of contrast. However, recent advances in quantita-
tive phase imaging (QPI) of transparent microscopic specimens
using digital holographic microscopy (DHM) have facilitated
observation of unstained living cells in ways that were previ-
ously impossible. This type of microscopy relies on the different
optical densities of the specimen and surrounding medium, pro-
ducing a difference in phase between the light passing through
the specimen and the light passing through the medium,
ultimately generating an interference pattern. In DHM, only
a single recorded image is required to obtain the fringe pat-
tern resulting from the interference between a reference wave
and the image of the wavefront diffracted by the specimen.
From the pattern, phase changes introduced by the specimen are
easily retrieved to produce a quantitative phase map. These
phase changes encode the information about the refractive index
and thickness of the specimen and as a result, QPI-DHM can be
used to analyze illnesses in which the refractive index and/or
morphology of cells or tissues are distorted.1–4
The application of QPI-DHM to medical diagnosis relies on
the high accuracy of the phase map measurements. The optical
capture and subsequent computational processing both have a
significant role in this hybrid technique. However, our research
group has recently demonstrated that the optical capture stage
controls the accuracy of QPI-DHM.5–7 Specifically, we showed
that QPI-DHM operating in telecentric mode—producing a 2D
image of a 3D object—provides very accurate diffraction-limited
quantitative phase images with minimal post-processing. This
accuracy can be very useful for the diagnosis of different
diseases and for specimen identification. Here, we show how
this type of microscopy can be used in the diagnosis of diabetes
Figure 1. Schematic of the experimental setup for diabetes screening.
The digital holographic microscope operates in telecentric mode: the
aperture stop of the objective is placed at the front focal plane of the
tube lens. fTL: Focal length of the tube lens. He-Ne: Helium-neon.
mellitus (DM), using a simple procedure that requires a small
amount of blood.
Telecentric DHM has a potential application as a technique for
the screening of DM,8 which is undoubtedly one of the most
challenging health problems of this century. Assessment and
control of hyperglycemic states is one of the main methods of
minimizing the risk of developing the medical complications
associated with DM. Currently, the gold standard method
to evaluate hyperglycemia in patients with DM and obtain
long-term glycemic control is the determination of glycated
hemoglobin (HbA1c) concentration. This measurement is usu-
ally made by high-performance liquid chromatography (HPLC),
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a complex chemical process requiring the extraction of blood
from the antecubital vein. Telecentric DHM can reduce this
complexity by imaging phase maps of red blood cells (RBCs).
To evaluate changes to the phase maps of people with
DM, we measured phase maps of RBC samples from a group
of healthy controls and from patients with DM who were
being treated with insulin injections. For each person, we
prepared a sample by smearing a capillary blood drop on a glass
slide. Each slide was placed in the optical object path of our
telecentric digital holographic microscope (see Figure 1). After
applying the reconstruction algorithm, we obtained the phase
map for each person. Figure 2 shows the phase maps corre-
sponding to one control and one patient with DM. The phase
images are pseudocolored so the differences between the phase
maps of the healthy control and the patient with DM can be
easily visualized. The phase maps clearly show the phase
values of diabetic RBCs are significantly higher than those
obtained from the healthy person, indicating a difference in the
refractive index and/or morphology of the RBCs.
Once the blood smears were imaged, we obtained a mean
phase value for each participant by averaging the central phase
values of 20 RBCs. Figure 3 (top) shows histograms of the
RBC phases from healthy individuals and patients with DM.
Again, we observe that the phase values of healthy people were
significantly smaller than those of participants with DM: the
mean phase values were 3.15˙0.13rad and 3.72˙0.15rad, respec-
tively. Notably, the phase values of the two groups were clearly
separated: the phase values are 2.94–3.30rad for healthy RBCs
and 3.51–4.01rad for DM RBCs. From this gap, we can conclude
that phase values above 3.40rad correspond to patients with DM.
Figure 2. Pseudocolored phase maps of healthy red blood cells (RBCs)
(top) and diabetic RBCs (bottom). The image area is 63.563.5m2.
Figure 3. Histograms of mean phase values (top) and glycated
hemoglobin (HbA1c) (bottom) of the healthy control group (yellow) and
the participants with diabetes mellitus (DM) (turquoise).
As a final test to validate telecentric DHM as a technique
to screen for diabetes, we compared our phase values with
the HbA1c values obtained using the standard HPLC method:
see Figure 3 (bottom). The correlation coefficient measured
between these two distributions was 0.739. This high correlation
coefficient and the clear separation of phase measurements
between the two populations confirms that DHM could
potentially be used to diagnose diabetes and to evaluate long-
term glycemic control in patients with diabetes.
In summary, we have shown that the quantitative phase maps
provided by telecentric DHM could be used for the diagnosis of
diabetes, and to evaluate long-term glycemic control in patients
with diabetes. The main advantages of this technique are that
it is minimally invasive, it can be performed at any time, and
the phase measurements are rapidly obtained. Our future work
in this field will include the experimental implementation of a
DHM module in a conventional microscope, and the investiga-
tion of further applications of telecentric DHM.
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